Gilder Gagnon Howe & Co’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2014
Q3 | – | Sell |
-25,454
| Closed | -$989K | – | 305 |
|
|
2014
Q2 | $989K | Sell |
25,454
-386,371
| -94% | -$15M | 0.01% | 223 |
|
|
2014
Q1 | $17.3M | Buy |
411,825
+5,497
| +1% | +$231K | 0.24% | 97 |
|
|
2013
Q4 | $13.3M | Buy |
406,328
+127,436
| +46% | +$4.18M | 0.19% | 101 |
|
|
2013
Q3 | $7.53M | Buy |
278,892
+141,765
| +103% | +$3.83M | 0.12% | 122 |
|
|
2013
Q2 | $3.2M | Buy |
+137,127
| New | +$3.2M | 0.06% | 168 |
|